Serotonin transporter SERT: a novel immune checkpoint for CD8+ T cell antitumor therapy
This Highlight describes a key observation where serotonin transporter (SERT) was shown to suppress CD8+ T cell antitumor responses via depletion of intratumoral 5-HT. While selective serotonin reuptake inhibitors (SSRIs)—among the most widely u…